Daily pill can double survival time for world’s deadliest cancer, trial shows
Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest (…)
Site référencé: The Guardian (Asia Pacific)
3944.jpg?width=140&quality=85&auto=format&fit=max&s=3b43846a257ff075508ffce8a1f47d39, 3944.jpg?width=460&quality=85&auto=format&fit=max&s=7cc9fbebcd71e89831ebf650f0cbb809, 3944.jpg?width=700&quality=85&auto=format&fit=max&s=3205c77dea48b719949e7d6320e5d2ce
The Guardian (Asia Pacific)
Crossword editor’s desk : celebrating 30,000 cryptics with a treasure hunt
2/06/2026
The return of the bridal suit : will Dua Lipa’s look change the face of weddings ?
2/06/2026
AI won’t decimate the arts. We must interrogate it, but we can collaborate with it
2/06/2026
BP backs Amanda Blanc to lead search for new chair despite investor concerns
2/06/2026
How will AI sycophancy change us ? Early signs are not encouraging | Arwa Mahdawi
2/06/2026
‘An endless silent scream feeling’ : artist Roni Horn on horror, hope and landing in a lake in Iceland
2/06/2026